Letrozole (CGS 20267) CAS:112809-51-5
Letrozole (CGS 20267)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1493 | 2g | 165.00 | + Add to cart |
|
| R-C-1493 | 5g | 225.00 | + Add to cart |
|
| R-C-1493 | 10g | 425.00 | + Add to cart |
|
|
|
||||
Product description
Letrozole(CGS 20267)is a third generation inhibitor of aromatase with IC50 of 0.07-20 nM in cell-free assays.It has no effect on the plasma levels of 17α-OH progesterone,thyroid-stimulating hormone(TSH),luteinizing hormone(LH),follicle-stimulating hormone(FSH),or androstenedione and does not affect normal urine electrolyte excretion or thyroid function in clinical studies.Letrozole induces autophagy.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---Letrozole (CGS 20267)
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


